[en] The results and conclusions of a working group held to discuss the state of knowledge and information needs concerning potential climate change implications for forestry are presented. The lack of knowledge in some basic processes, for example physiological and genetics, limits ability to evaluate and project the adaptation and responses to climate change. Areas where knowledge is weak include: the potential maximum productivity for a given climate region; the extent to which climate change can be accomodated by genetic adaptation; ways to improve the temporal/spatial distribution of projected precipitation and temperature changes and their magnitudes; the effect of global warming on fire severity and behavior; the current lightning distribution and relationship to fire and the response of this to global warming; socio-economic needs and constraints for management of wilderness areas; carbon dioxide enrichment effects on forest growth and water use efficiency; carbon benefits associated with afforestation and other carbon sequestering programs; impacts of forest practices on the carbon cycle; and the definition of biological diversity on the Great Plains. Recommended research initiatives include improving climate projections, targetted biological process research, monitoring for change and adaptive management, and development of decision support systems

[en] Cancer remains a leading cause of death in Canada and worldwide. Whilst advances in anatomical imaging to detect and monitor malignant disease have continued over the last few decades, limitations remain. Functional imaging, such as positron emission tomography (PET), has improved the sensitivity and specificity in detecting malignant disease. In combination with computed tomography (CT), PET is now commonly used in the oncology setting and is an integral part of many cancer patients' pathways. Although initially the CT component of the study was purely for attenuation of the PET imaging and to provide anatomical coregistration, many centers now combine the PET study with a diagnostic quality contrast enhanced CT to provide one stop staging, thus refining the patient's pathway. The commonest tracer used in everyday practice is FDG (F18-fluorodeoxyglucose). There are many more tracers in routine clinical practice and those with emerging roles, such as 11C-choline, useful in the imaging of prostate cancer; 11C-methionine, useful in imaging brain tumours; C11- acetate, used in imaging hepatocellular carcinomas; 18F-FLT, which can be used as a marker of cellular proliferation in various malignancies; and F18-DOPA and various 68Ga-somatostatin analogues, used in patients with neuroendocrine tumours. In this article we concentrate on FDG PETCT as this is the most commonly available and widely utilised tracer now used to routinely stage a number of cancers. PETCT alters the stage in approximately one-third of patients compared to anatomical imaging alone. Increasingly, PETCT is being used to assess early metabolic response to treatment. Metabolic response can be seen much earlier than a change in the size/volume of the disease which is measured by standard CT imaging. This can aid treatment decisions in both in terms of modifying therapy and in addition to providing important prognostic information. Furthermore, it is helpful in patients with distorted anatomy from surgery or radiotherapy when there is suspicion of recurrent or residual disease. FDG PETCT is not specific for malignancy and can also be used for diagnosing and monitoring a number of inflammatory and infectious conditions that can be difficult to diagnose on anatomical imaging, some of which carry significant morbidity. FDG PETCT is increasingly used in patients with pyrexia of unknown origin and in patients with metastatic malignancies of unidentified primary on conventional imaging. This article reviews the uses of PETCT including an overview of the more common incidental lesions and conditions. It also provides guidance of how to approach a PETCT as a nonradionuclide radiologist and how to interpret a study in the multidisciplinary team setting. (author)

[en] 'Full text:' Building codes and standards and the climatic design values embedded within these legal to semi-legal documents have profound safety, health and economic implications for Canada's infrastructure systems. The climatic design values that have been used for the design of almost all of today's more than $5.5 Trillion in infrastructure are based on historical climate data and assume that the extremes of the past will represent future conditions. Since new infrastructure based on codes and standards will be built to survive for decades to come, it is critically important that existing climatic design information be as accurate and up-to-date as possible, that the changing climate be monitored to detect and highlight vulnerabilities of existing infrastructure, that forensic studies of climate-related failures be undertaken and that codes and standards processes incorporate future climates and extremes as much as possible. Uncertainties in the current climate change models and their scenarios currently challenge our ability to project future extremes regionally and locally. Improvements to the spatial and temporal resolution of these climate change scenarios, along with improved methodologies to treat model biases and localize results, will allow future codes and standards to better reflect the extremes and weathering conditions expected over the lifespan of structures. In the meantime, other information and code processes can be used to incorporate changing climate conditions into upcoming infrastructure codes and standards, to “bridge” the model uncertainty gap and to complement the state of existing projections. This presentation will outline some of the varied information and processes that will be used to incorporate climate change adaptation into the next development cycle of the National Building Code of Canada and numerous other national CSA infrastructure standards. (author)

No abstract available